Last reviewed · How we verify

NCT07347873

Diagnostic Accuracy of the Clinical Tests and the Ultrasonography in Lateral Elbow Tendinopathy

Recruiting now Last updated 16 January 2026
What this trial tests

trial in Lateral Elbow Tendinopathy (Tennis Elbow) in 100 participants. Currently enrolling.

Timeline
17 October 2025
Primary endpoint
31 January 2026
26 March 2026

Quick facts

Lead sponsorMarmara University
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment100
Start date17 October 2025
Primary completion31 January 2026
Estimated completion26 March 2026
Sites1 location across Turkey (Türkiye)

Conditions studied

Sponsor

Marmara University

Who can join

Adults 18 to 60, any sex, with Lateral Elbow Tendinopathy (Tennis Elbow). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Lateral elbow tendinopathy (LET) is the most common cause of elbow pain. Even though provocation tests such as Cozen's test, Mill's test or Maudsley test; musculoskeletal ultrasound or magnetic resonance imaging can be used for diagnosis, gold standard method is yet to be determined. Purpose of this study is to determine the sensitivity and specificity of clinical tests and ultrasonography in diagnosis of LET.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Lateral Elbow Tendinopathy (Tennis Elbow)

Currently open trials in the same condition.

Other Marmara University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07347873.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing